X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CHEMOTHERAPY

期刊標題檢索 CHEMOTHERAPY 最新評論: This article requires 80 references?! (2023-04-20)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CHEMOTHERAPY]您好,您是該頁面的第 34084 位訪客。

期刊簡介
期刊名稱CHEMOTHERAPY CHEMOTHERAPY
LetPub Score
5.1
50 ratings
Rate

Reputation
6.4

Influence
3.7

Speed
7.0

期刊簡稱CHEMOTHERAPY
ISSN0009-3157
E-ISSN1421-9794
h-index49
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.800.6630.499
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q282 / 272
Category: Medicine
Subcategory: Oncology
Q2134 / 404
Category: Medicine
Subcategory: Infectious Diseases
Q2115 / 344
Category: Medicine
Subcategory: Pharmacology
Q2126 / 313
Category: Medicine
Subcategory: Drug Discovery
Q270 / 157

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
This journal publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamics properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide.
官方網站http://www.karger.com/Journal/Home/223834
在線稿件提交http://oper1.karger.com/xpresstrack/submissions/?jid=144
開放訪問No
出版商S. Karger AG
主題領域医学
出版國/地區SWITZERLAND
發行頻率隔月刊行
創刊年1968
每年文章數29每年文章數趨勢
黃金OA百分比17.00%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ3221/322
PHARMACOLOGY & PHARMACYSCIEQ3222/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0009-3157%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【CHEMOTHERAPY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498667
    PHYTOMEDICINE343773
    LIFE SCIENCES291010
    PHARMACOLOGICAL RESEARCH244007
    International Journal of Pharmaceutics242769
    European Journal of Pharmacology204563
    BIOCHEMICAL PHARMACOLOGY203066
    JOURNAL OF NATURAL PRODUCTS196875
    BRITISH JOURNAL OF PHARMACOLOGY165450
    MOLECULAR PHARMACEUTICS162992
  •  

    CHEMOTHERAPY CHEMOTHERAPY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CHEMOTHERAPY] 的評論撰寫評論
作者: 北风芊芊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-20 13:39:27 評論於
This article requires 80 references?!
(0) 讚! | 北风芊芊

作者: 北风千波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-21 15:56:13 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0
Experience sharing: Submitted on 2022.12.8, revised format on 2023.1.4, external review started on 2023.1.17, major revisions delayed due to the Spring Festival, revisions completed on 2023.3.13, formally accepted on 2023.3.20
(0) 讚! | 北风千波

作者: 通背若淑


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-04-06 15:13:51 評論於
Are there any great contributors recently? It seems very difficult to submit to this magazine as they only publish over 50 articles per year
(0) 讚! | 通背若淑

作者: 雷电红瑞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-01-02 19:27:44 評論於
Review speed: 1.0 | Submission hit rate: 50.0
Experience Sharing: Just submitted, rejected in four days, reason given was lack of innovation in the topic, language barrier
(0) 讚! | 雷电红瑞

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-14 14:09:06 評論於
Anyway, this is the look of the bear, there will be no change, as long as it doesn't fall, it's fortunate enough
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-07-01 23:04:50 評論於
Crossed over 2 points, will it be a bit more exciting next year, very hopeful
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-08-25 12:30:38 評論於
Review process lasted for six months, with over a dozen questions raised, but they were not very sharp and did not require additional experiments. After one month of preparation, the paper was resubmitted and quickly accepted!
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-04-01 12:39:42 評論於
It has been four months and still no news, so slow!
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CHEMOTHERAPY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*